Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea flag South Korea · Delayed Price · Currency is KRW
29,000
+50 (0.17%)
Apr 29, 2026, 3:30 PM KST

Daihan Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
43,97361,302101,50190,85783,765
Upgrade
Short-Term Investments
3,9628,9342,8586,75012,650
Upgrade
Trading Asset Securities
41,6007,000---
Upgrade
Cash & Short-Term Investments
89,53577,237104,35997,60796,415
Upgrade
Cash Growth
15.92%-25.99%6.92%1.24%42.63%
Upgrade
Accounts Receivable
31,00131,22530,85731,30629,101
Upgrade
Other Receivables
2,9781,34785.13932.2171.32
Upgrade
Receivables
33,97932,57230,94232,23829,172
Upgrade
Inventory
33,93326,73523,58824,93920,632
Upgrade
Prepaid Expenses
90.7182.879.9474.87107.4
Upgrade
Other Current Assets
954.1739.83935.431,0261,212
Upgrade
Total Current Assets
158,492137,366159,905155,886147,539
Upgrade
Property, Plant & Equipment
153,399134,441125,853113,236113,831
Upgrade
Long-Term Investments
35,34252,1758,0657,39410,129
Upgrade
Other Intangible Assets
397.01397.01397.01397.01397.01
Upgrade
Long-Term Accounts Receivable
-00-0-
Upgrade
Long-Term Deferred Tax Assets
----398.84
Upgrade
Other Long-Term Assets
32.7432.183367.34247.34
Upgrade
Total Assets
347,663324,411294,252276,980272,542
Upgrade
Accounts Payable
17,75417,75317,22718,10415,108
Upgrade
Accrued Expenses
818.71795.63777.66739.86674.52
Upgrade
Short-Term Debt
---2,5002,700
Upgrade
Current Portion of Long-Term Debt
----6,800
Upgrade
Current Portion of Leases
13.2626.27--16.57
Upgrade
Current Income Taxes Payable
2,3864,3574,4665,1305,662
Upgrade
Other Current Liabilities
22,53519,71218,83016,21115,158
Upgrade
Total Current Liabilities
43,50842,64441,30042,68646,119
Upgrade
Long-Term Debt
---4,00014,000
Upgrade
Long-Term Leases
-2.76---
Upgrade
Pension & Post-Retirement Benefits
1,9214,6264,0803,5559,109
Upgrade
Long-Term Deferred Tax Liabilities
899.94555303.87775.87-
Upgrade
Other Long-Term Liabilities
1,121589.7594.63565.8506.37
Upgrade
Total Liabilities
47,45048,41846,27851,58269,734
Upgrade
Common Stock
3,0003,0003,0003,0003,000
Upgrade
Additional Paid-In Capital
175.92175.92175.92175.92175.92
Upgrade
Retained Earnings
290,902266,545238,525216,086190,078
Upgrade
Treasury Stock
-3,418-3,418-3,418-3,418-
Upgrade
Comprehensive Income & Other
9,5549,6919,6919,5549,554
Upgrade
Shareholders' Equity
300,214275,994247,974225,398202,808
Upgrade
Total Liabilities & Equity
347,663324,411294,252276,980272,542
Upgrade
Total Debt
13.2629.03-6,50023,517
Upgrade
Net Cash (Debt)
89,52277,208104,35991,10772,899
Upgrade
Net Cash Growth
15.95%-26.02%14.55%24.98%87.68%
Upgrade
Net Cash Per Share
-13130.5317748.2115223.1612149.75
Upgrade
Filing Date Shares Outstanding
-5.885.885.886
Upgrade
Total Common Shares Outstanding
-5.885.885.886
Upgrade
Working Capital
114,98594,722118,604113,200101,420
Upgrade
Book Value Per Share
-46937.7242172.4638333.0133801.34
Upgrade
Tangible Book Value
299,817275,597247,577225,001202,411
Upgrade
Tangible Book Value Per Share
-46870.2042104.9438265.4933735.17
Upgrade
Land
59,38559,38559,38056,79655,727
Upgrade
Buildings
89,10168,86261,78159,35449,971
Upgrade
Machinery
108,69086,00781,35878,43877,615
Upgrade
Construction In Progress
1,94818,15815,4843,2258,857
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.